Evaluation the Effect of 50 and 100 mg Doses of Essential Oil on Glycemic Indices, Insulin Resistance and Serum Inflammatory Factors on Patients with Diabetes Type II: A Double-blind Randomized Placebo-controlled Clinical Trial

Overview

Journal J Tradit Complement Med

Specialty Rehabilitation Medicine

Date 2017 Jul 21

PMID 28725629

Citations 16

Authors

Sahar Jafari

Roghieh Sattari

Said Ghavamzadeh

Affiliations

Soon will be listed here.

Abstract

Aim: The purpose of this study was to evaluate the effect of 50 and 100 mg doses of green cumin essential oil on glycemic and inflammatory indices in patients with diabetes type II.

Method: In this randomized double-blind placebo-controlled clinical trial, subjects were divided into three groups after selecting them randomly according to the inclusion criteria: 1 - capsule (100 mg/day,n = 33), 2 - capsule (50 mg/day, n = 33), and 3 - placebo (n = 33). Before and after 8 weeks of intervention, a blood sample was taken.

Findings: The findings demonstrated that the mean of the FBS, glycosylated hemoglobin (HgA1c) and the serum levels of insulin were significantly decreased and insulin sensitivity (HOMA-IR) was significantly increased in the groups receiving the 100 mg supplement (P < 0.001) and 50 mg supplement, but these indices were increased in the placebo group. The mean serum levels of TNF-α and hsCRP were significantly decreased, and serum levels of adiponectin was significantly increased at the end of the study in the groups receiving 100 mg (P < 0.001) and 50 mg (P = 0.008) supplement as well as in the group who received the placebo. There were no significant change in HOMA-B and QUICKI as insulin resistance parameters.

Discussion And Conclusion: Administering supplement in patients with diabetes type II may decrease the serum levels of insulin, FBS, and glycosylated hemoglobin and also the inflammatory indices of TNF-α and hsCRP and increased the serum levels of adiponectin. In addition it may control the complications of diabetes type II in these patients.

Citing Articles

Multiple nanotechnological approaches using natural compounds for diabetes management.

Stoleru O, Burlec A, Mircea C, Felea M, Macovei I, Hancianu M J Diabetes Metab Disord. 2024; 23(1):267-287.

PMID: 38932892 PMC: 11196251. DOI: 10.1007/s40200-023-01376-1.

Traditional Herbal Medications Utilized in the Indian Medical System forthe Management of Diabetes: An Updated Review and Clinical Implications.

Sachan K, Verma S, Arora K, Bharti U, Singh P, Singh S Curr Diabetes Rev. 2024; 20(9):e230124226017.

PMID: 38275040 DOI: 10.2174/0115733998273029231121094725.

Antioxidant and Hypoglycemic Potential of Essential Oils in Diabetes Mellitus and Its Complications.

Bungau S, Vesa C, Bustea C, Purza A, Tit D, Brisc M Int J Mol Sci. 2023; 24(22).

PMID: 38003691 PMC: 10671358. DOI: 10.3390/ijms242216501.

Aromatic Plant-Based Functional Foods: A Natural Approach to Manage Cardiovascular Diseases.

Zuzarte M, Girao H, Salgueiro L Molecules. 2023; 28(13).

PMID: 37446792 PMC: 10343196. DOI: 10.3390/molecules28135130.

Treatment on Nature's lap: Use of herbal products in the management of hyperglycemia.

Giri S, Sahoo J, Roy A, Kamalanathan S, Naik D World J Diabetes. 2023; 14(4):412-423.

PMID: 37122430 PMC: 10130899. DOI: 10.4239/wjd.v14.i4.412.

References

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

Taghizadeh M, Memarzadeh M, Asemi Z, Esmaillzadeh A . Effect of the cumin cyminum L. Intake on Weight Loss, Metabolic Profiles and Biomarkers of Oxidative Stress in Overweight Subjects: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Ann Nutr Metab. 2015; 66(2-3):117-124. DOI: 10.1159/000373896. View

Dhandapani S, Subramanian V, Rajagopal S, Namasivayam N . Hypolipidemic effect of Cuminum cyminum L. on alloxan-induced diabetic rats. Pharmacol Res. 2002; 46(3):251-5. DOI: 10.1016/s1043-6618(02)00131-7. View

Mirza S, Hossain M, Mathews C, Martinez P, Pino P, Gay J . Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine. 2011; 57(1):136-42. PMC: 3270578. DOI: 10.1016/j.cyto.2011.09.029. View

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

Yaturu S, Rains J, Jain S . Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes. Cytokine. 2008; 44(1):168-71. DOI: 10.1016/j.cyto.2008.07.471. View

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 Suppl 1:S62-9. PMC: 2797383. DOI: 10.2337/dc10-S062. View

Zhang H, Zhou J, Zhang L, Ma J, Sun Y, Zhao Y . Characteristics of blood glucose excursions in type 2 diabetes mellitus patients with three different Traditional Chinese Medicine syndromes. J Tradit Chin Med. 2015; 35(5):537-45. DOI: 10.1016/s0254-6272(15)30136-9. View

10.

Chowdhury T, Escudier V . Poor glycaemic control caused by insulin induced lipohypertrophy. BMJ. 2003; 327(7411):383-4. PMC: 1126795. DOI: 10.1136/bmj.327.7411.383. View

11.

Pisprasert V, Ingram K, Lopez-Davila M, Munoz A, Garvey W . Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care. 2012; 36(4):845-53. PMC: 3609485. DOI: 10.2337/dc12-0840. View

12.

Matteucci E, Giampietro O . Oxidative stress in families of type 1 diabetic patients. Diabetes Care. 2000; 23(8):1182-6. DOI: 10.2337/diacare.23.8.1182. View

13.

Asemi Z, Zare Z, Shakeri H, Sabihi S, Esmaillzadeh A . Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 2013; 63(1-2):1-9. DOI: 10.1159/000349922. View

14.

Stratton I, Adler A, Neil H, Matthews D, Manley S, Cull C . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258):405-12. PMC: 27454. DOI: 10.1136/bmj.321.7258.405. View

15.

Caballero A . Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res. 2003; 11(11):1278-89. DOI: 10.1038/oby.2003.174. View

16.

Kalaivani P, Saranya R, Ramakrishnan G, Ranju V, Sathiya S, Gayathri V . Cuminum cyminum, a dietary spice, attenuates hypertension via endothelial nitric oxide synthase and NO pathway in renovascular hypertensive rats. Clin Exp Hypertens. 2013; 35(7):534-42. DOI: 10.3109/10641963.2013.764887. View

17.

Barrett-Connor E . Diabetes and heart disease. Diabetes Care. 2003; 26(10):2947-58. DOI: 10.2337/diacare.26.10.2947. View

18.

Badr G, Mahmoud M, Farhat K, Waly H, Zin Al-Abdin O, Rabah D . Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling. Lipids Health Dis. 2013; 12:37. PMC: 3608164. DOI: 10.1186/1476-511X-12-37. View

19.

Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F . Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009; 9:167. PMC: 2697989. DOI: 10.1186/1471-2458-9-167. View

20.

Patil S, Takalikar S, Joglekar M, Haldavnekar V, Arvindekar A . Insulinotropic and β-cell protective action of cuminaldehyde, cuminol and an inhibitor isolated from Cuminum cyminum in streptozotocin-induced diabetic rats. Br J Nutr. 2013; 110(8):1434-43. DOI: 10.1017/S0007114513000627. View